Noveprim Overview

  • Founded
  • 1990
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 3

Noveprim General Information

Description

Provider of Cynomolgus macaques breeding services. The company traps, breeds and exports Cynomolgus macaques to laboratories for biomedical, pharmaceutical and toxicological research purposes. It also provides boarding facilities in country of origin, just in time delivery all over the world, real time web-access to client owned animal data boarded in its facilities and custom made pre-screening and quarantine services upon client request.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Commercial Services
Primary Office
  • Le vallon, old grand port
  • Mahébourg
  • Mauritius
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Noveprim Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Noveprim‘s full profile, request access.

Request a free trial

Noveprim Executive Team (2)

Name Title Board Seat Contact Info
Bruno Jullienne General Manager, Co-Chief Executive Officer & Chief Operating Officer
To view Noveprim’s complete executive team members history, request access »

Noveprim Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Noveprim‘s full profile, request access.

Request a free trial